Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis.
作者信息
Heudobler Daniel, Reichle Albrecht, Ghibelli Lina
机构信息
Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.
Department Biology, Universita' di Roma Tor Vergata, Rome, Italy.
出版信息
Front Pharmacol. 2021 Oct 7;12:779021. doi: 10.3389/fphar.2021.779021. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis.
Front Pharmacol. 2021 Oct 7;12:779021. doi: 10.3389/fphar.2021.779021. eCollection 2021.
2
Diagnosis of toxoplasmosis in children with malignancy.
J Egypt Soc Parasitol. 2000 Aug;30(2):523-36.
3
Distribution of ABO blood groups in acute leukaemias and lymphomas.
Ann Hematol. 2004 Sep;83(9):584-7. doi: 10.1007/s00277-004-0888-1. Epub 2004 Jun 3.
4
The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.
Klin Padiatr. 1997 Jul-Aug;209(4):235-42. doi: 10.1055/s-2008-1043956.
5
Editorial: Tumor Systems Biology: How to Therapeutically Redirect Dysregulated Homeostasis in Tumor Systems (i.e., Anakoinosis).
Front Oncol. 2020 Sep 2;10:1675. doi: 10.3389/fonc.2020.01675. eCollection 2020.
6
Expression of enolases in T cell tumors and Hodgkin's disease.
Lab Invest. 1990 Dec;63(6):792-7.
7
No involvement of bovine leukemia virus in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
Cancer Res. 1988 May 15;48(10):2919-22.
8
Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas.
Cancer. 1990 Jul 1;66(1):80-8. doi: 10.1002/1097-0142(19900701)66:1<80::aid-cncr2820660116>3.0.co;2-9.
9
Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin's lymphoma and T-cell non-Hodgkin's lymphoma.
Haematologica. 2011 Nov;96(11):1723-7. doi: 10.3324/haematol.2011.041921. Epub 2011 Jul 26.
10
Editorial: Anakoinosis for promoting tumor tissue editing: Novel therapeutic opportunities for establishing clinically relevant tumor control by targeting tumor plasticity.
Front Oncol. 2022 Sep 13;12:1005381. doi: 10.3389/fonc.2022.1005381. eCollection 2022.
引用本文的文献
1
Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance.
Cancers (Basel). 2023 Dec 29;16(1):180. doi: 10.3390/cancers16010180.
2
Unlocking the Potential: Novel NSAIDs Hybrids Unleash Chemopreventive Power toward Liver Cancer Cells through Nrf2, NF-κB, and MAPK Signaling Pathways.
Molecules. 2023 Jul 30;28(15):5759. doi: 10.3390/molecules28155759.
本文引用的文献
1
Anti-Cancer Potential of Synthetic Oleanolic Acid Derivatives and Their Conjugates with NSAIDs.
Molecules. 2021 Aug 16;26(16):4957. doi: 10.3390/molecules26164957.
2
Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue-Going Beyond Apoptosis Induction.
Front Oncol. 2019 Dec 20;9:1408. doi: 10.3389/fonc.2019.01408. eCollection 2019.
3
Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis.
Front Pharmacol. 2018 Nov 28;9:1357. doi: 10.3389/fphar.2018.01357. eCollection 2018.
4
Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue.
Int J Mol Sci. 2018 Nov 9;19(11):3540. doi: 10.3390/ijms19113540.
5
Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma.
Mol Cell Proteomics. 2017 Jan;16(1):86-99. doi: 10.1074/mcp.M116.063313. Epub 2016 Nov 22.
6
Rosiglitazone prevents graft-versus-host disease (GVHD).
Transpl Immunol. 2012 Oct;27(2-3):128-37. doi: 10.1016/j.trim.2012.09.001. Epub 2012 Sep 13.
7
Antiangiogenic therapy in metastatic prostate carcinoma complicated by cutaneous lupus erythematodes.
Lancet Oncol. 2006 Aug;7(8):695-7. doi: 10.1016/S1470-2045(06)70798-7.
Zotero 插件